Read + Share
Papi A, Corren J, Castro M, Domingo C, et al. Dupilumab reduced impact of severe exacerbations on lung function in patients
with moderate-to-severe type 2 asthma. Allergy 2022 Jul 28. doi: 10.1111/all.15456.
PMID: 35899469
|
 |
|
Papi A, Corren J, Castro M, Domingo C, et al. Dupilumab reduced impact of severe exacerbations on lung function in patients
with moderate-to-severe type 2 asthma. Allergy 2022 Jul 28. doi: 10.1111/all.15456.
PMID: 35899469
|
|
|
|